Rapamycin mediates mTOR signaling in reactive astrocytes and reduces retinal ganglion cell loss
- 1 November 2018
- journal article
- research article
- Published by Elsevier in Experimental Eye Research
- Vol. 176, 10-19
Abstract
No abstract availableKeywords
Funding Information
- National Natural Science Foundation of China (81271425, 81260148)
- Natural Science Foundation of Jiangxi (20151BBG70243)
This publication has 48 references indexed in Scilit:
- mTOR Signaling in Growth Control and DiseaseCell, 2012
- Astrocytes: biology and pathologyActa Neuropathologica, 2009
- Molecular dissection of reactive astrogliosis and glial scar formationTrends in Neurosciences, 2009
- The Rheb–mTOR Pathway Is Upregulated in Reactive Astrocytes of the Injured Spinal CordJournal of Neuroscience, 2009
- Axons of retinal ganglion cells are insulted in the optic nerve early in DBA/2J glaucomaJournal of Cell Biology, 2007
- AKT/PKB Signaling: Navigating DownstreamCell, 2007
- Rapamycin induces feedback activation of Akt signaling through an IGF-1R-dependent mechanismOncogene, 2006
- Phosphorylation and Regulation of Akt/PKB by the Rictor-mTOR ComplexScience, 2005
- Pten Loss Causes Hypertrophy and Increased Proliferation of Astrocytes In vivo Cancer Research, 2004
- PTEN , a Putative Protein Tyrosine Phosphatase Gene Mutated in Human Brain, Breast, and Prostate CancerScience, 1997